Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy

Terapevticheskii Arkhiv

Volumn 80, Issue 1, 2008, Pages 52-56

  Bondar, I A ^a   Klimontov, V V ^a   Nadeev, A P ^a  

^a NONE

Author keywords

Cytokines; Diabetic nephropathy; Inflammation; Type 1 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; INTERLEUKIN 1BETA; LEUKOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ARTICLE; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; URINE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHEMOKINE CCL5; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MACROPHAGES; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA;

EID: 41049098623     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Russian source
2. Furuta T., Saito T., Ootaka T. et al. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 1993; 21 (5): 480-485.
3. Sassy-Prigent C., Heudes D., Mandet C. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000; 49 (3): 466-475.
4. Mezzano S., Droguett A., Burgos M. E. et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. 2003; suppl. 86: S64-S70.
5. Mezzano S., Aros C., Droguett A. et al. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transplant. 2004; 19 (10): 2505-2512.
6. Hartner A., Veelken R., Wittmann M. et al. Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrol. 2005; 6 (1): 1-6.
7. Chow F. Y., Nikolic-Paterson D. J., Ozols E. et al. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 2006; 69 (1): 73-80.
8. Russian source
9. Satriano J. A., Banas B., Luckow B. et al. Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J. Am. Soc. Nephrol. 1997; 8 (4): 596-603.
10. Banba N., Nakamura T., Matsumura M. et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int. 2000; 58 (2): 684-690.
11. Korpinen E., Teppo A. M., Hukkanen L. et al. Urinary transforming growth factor-betal and alphal-microglobulin in children and adolescents with type 1 diabetes. Diabet. Care 2000; 23 (5): 664-668.
12. Tesch G. H., Yang N., Yu H. et al. Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol. Dial. Transplant. 1997; 12 (6): 1109-1115.
13. Gu L., Hagiwara S., Fan Q. et al. role of receptor for advanced glycation end-products and signaling events in advanced glycation and-product-induced monocyte chemoattractant protein1 expression in differentiated mouse podocytes. Nephrol. Dial. Transplant. 2006; 21 (2): 299-313.
14. Chen S., Jim B., Ziyadeh F. N. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin. Nephrol. 2003; 23 (6): 532-543.
15. Ando T., Okuda S., Yanagida T. et al. Localization of TGFβ and its receptors in the kidney. Miner. Electrolyte Metab. 1998; 24 (1-2): 149-153.
16. Cohen M. P., Ziyadeh F. N., Hong S. W. et al. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-betal. Kidney Int. 2002; 61 (6): 2025-2032.
17. Kalender B., Ozturk M., Tuncdemir M. et al. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats. Acta Histochem. 2002; 104 (2): 123-130.
18. Wahab N. A., Schaefer L., Weston B. S. et al. Glomerular expression of trombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their independent roles in mesangial response to diabetic stimuli. Diabetologia 2005; 48 (12): 2650-2660.
19. van Det N. F., Verhagen N. A., Tamsma J. T. et al. Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes 1997; 46 (5): 834-840.
20. Burton C. J., Combe C., Walt J. et al. Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol. Dial. Transplant. 1999; 14 (11): 2628-2633.
21. Russian source
22. Marisa C., Lucci I., Di Giulio C. et al. MCP-1 and MIP-2 expression and production in BB diabetic rat: effect of chronic hypoxia. Mol. Cell. Biochem. 2005; 276 (1-2): 105-111.
23. Vesey D. A., Cheung C. W., Cuttle L. et al. Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int. 2002; 62 (1): 31-40.
24. Wang S. N., LaPage J., Hirschberg R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int. 2000; 57 (3): 1002-1014.
25. Cheng J., Diaz Encamacion M. M., Warner G. M. et al. TGF-beta1 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process. Am. J. Physiol. Cell. Physiol. 2005; 289 (4): C959-C970.
26. Kobayashi T., Inoue T., Okada H. et al. Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-beta produced by tubular epithelial cells in response to high glucose. Clin. Exp. Nephrol. 2005; 9 (2): 114-121.
27. McLennan S. V., Fisher E., Martell S. Y. et al. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int. 2000; suppl. 77: S81-S87.
28. Pawluczyk I. Z., Harris K. P. Cytokine interactions promote synergistic fibronectin accumulation by mesangial cells. Kidney Int. 1998; 54 (1): 62-70.
29. Moutabarrik A., Nakanishi I., Zaid D. et al. Interleukin-1-beta activation of cultured glomerular epithelial cells. Exp. Nephrol. 1994; 2 (3): 196-204.
30. Montovani A., Bussolino F., Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol. Today 1997; 18 (5): 231-240.
31. Giunti S., Pinach S., Arnaldi L et al. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int. 2006; 69 (5): 856-863.
32. Biswas S. K., Lopes de Faria J. B. Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus. Am. J. Nephrol. 2006; 26 (5): 415-422.
33. Eddy A. A. Proteinuria and interstitial injury. Nephrol. Dial. Transplant. 2004; 19 (2): 277-281.
34. Chow F. Y., Nikolic-Paterson D. J., Atkins R. C., Tasch G. H. Macrophages in streptozoptocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol. Dial. Transplant. 2004; 19 (12): 2987-2996.
35. Chow F. Y., Nikolic-Paterson D. J., Ozols E. et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J. Am. Soc. Nephrol. 2005; 16 (6): 1711-1722.
36. Chow F., Ozols F., Nikolic-Paterson D. J. et al. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004; 65 (1): 116-128.
37. Russian source
38. Tam F. W., Sanders J. S., George A. et al. Urinary monocyte chemoattractant protein-1 (MCP-I) is a marker of active renal vasculitis. Nephrol. Dial. Transplant. 2004; 19 (11): 2761-2768.
39. Amann B., Tinzmann R., Angelkort B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabet. Care 2003; 26 (8): 2421-2425.
40. Kelly D. J., Chanty A., Gow R. M. et al. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J. Am. Soc. Nephrol. 2005; 16 (6): 1654-1660.